Coreline Soft announced it will introduce its next-generation chest AI platform AVIEW 2.0 at
RSNA 2025, showcasing how unified AI automation is redefining radiology workflows across pulmonary, cardiac, and airway pathologies.
AVIEW 2.0 moves beyond task-specific tools to deliver an integrated diagnostic ecosystem combining lung-cancer screening (LCS), coronary-artery calcium scoring (CAC), and COPD quantification into one streamlined pipeline. Clinical validation demonstrated up to 89% faster case throughput and 60% reduction in interpretation time compared to the previous generation.
The platform has already processed 2.5 million cases across 19 countries, and is deployed in large-scale screening programs throughout Europe (Germany, France, Italy) as well as major U.S. centers such as UMass Memorial Medical Center, Temple Lung Center, 3DR Labs, and ImageCare Radiology.
At RSNA 2025, Coreline will also present a live demonstration of its end-to-end AI workflow in the “Radiology Reimagined” zone, validating the full pathway—from triage and interpretation to reporting and quality management—under IHE and FHIR standards.
2025.11.10